Adaptive Phage Therapeutics - Ownership and Business Overview

Life ScienceCompany

Adaptive Phage Therapeutics Ownership

Who owns Adaptive Phage Therapeutics?

Adaptive Phage Therapeutics is owned by BiomX. It was acquired on March 18, 2024.

Adaptive Phage Therapeutics Business Overview

Where is Adaptive Phage Therapeutics headquartered?

Adaptive Phage Therapeutics is headquartered in Gaithersburg, Maryland.

What sector is Adaptive Phage Therapeutics in?

Adaptive Phage Therapeutics is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 191 acquisitions of life science companies in 2024, including 16 acquisitions by private equity firms, and 175 by strategics.

Adaptive Phage Therapeutics

Adaptive Phage Therapeutics, Inc.

708 Quince Orchard Road, Suite 205,
Gaithersburg, Maryland 20878
United States,
(844) 972-0500
www.aphage.com

Adaptive Phage Therapeutics is a U.S.-based privately-held, clinical-stage biotechnology company developing phage-based therapies to combat bacterial infections. Adaptive Phage Therapeutics is based in Gaithersburg, Maryland.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.